Silence Therapeutics plc (SLN) Discusses Top-Line Results From SANRECO Phase II Trial of Divesiran in Polycythemia Vera - Slideshow (NASDAQ:SLN) 2026-08-11
· seekingalpha.com
2026-08-11. The following slide deck was published by Silence Therapeutics plc in conjunction with this event.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...